The Swedish cardiopulmonary bioimage study re-examination: rationale, design, methods, and management of incidental findingsDepartment of Clinical Sciences Malmö, Lund University, Malmö, Sweden; Skåne University Hospital, Malmö, Sweden.
Department of Radiology, Institute of Clinical Sciences, Sahlgrenska Academy, Sahlgrenska University Hospital, ,University of Gothenburg | Region Västra Götaland, Gothenburg, Sweden.
Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden; Skåne University Hospital, Malmö, Sweden.
Uppsala Clinical Research Centre, Uppsala University, Uppsala, Sweden.
Department of Radiology, Institute of Clinical Sciences, Sahlgrenska Academy, Sahlgrenska University Hospital, ,University of Gothenburg | Region Västra Götaland, Gothenburg, Sweden.
Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
Department of Radiology, Institute of Clinical Sciences, Sahlgrenska Academy, Sahlgrenska University Hospital, ,University of Gothenburg | Region Västra Götaland, Gothenburg, Sweden.
Umeå universitet, Medicinska fakulteten, Institutionen för folkhälsa och klinisk medicin.
Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
Umeå universitet, Medicinska fakulteten, Institutionen för folkhälsa och klinisk medicin.
Umeå universitet, Medicinska fakulteten, Institutionen för folkhälsa och klinisk medicin.
Swedish Heart—Lung Foundation, Stockholm, Sweden.
Department of Health, Medicine & Caring Sciences, Linköping University, Linköping, Sweden; Department of Cardiology, Linköping University Hospital, Region Östergötland, Linköping, Sweden.
Uppsala Clinical Research Centre, Uppsala University, Uppsala, Sweden.
Department of Health, Medicine & Caring Sciences, Linköping University, Linköping, Sweden; Department of Cardiology, Linköping University Hospital, Region Östergötland, Linköping, Sweden.
Department of Health, Medicine & Caring Sciences, Linköping University, Linköping, Sweden; Department of Radiology, Linköping University Hospital, Region Östergötland, Linköping, Sweden.
Department of Health, Medicine & Caring Sciences, Linköping University, Linköping, Sweden.
Uppsala Clinical Research Centre, Uppsala University, Uppsala, Sweden.
Visa övriga samt affilieringar
2026 (Engelska)Ingår i: Journal of Internal Medicine, ISSN 0954-6820, E-ISSN 1365-2796, Vol. 299, nr 4, s. 467-480Artikel i tidskrift (Refereegranskat) Published
Abstract [en]
Objectives: To describe the rationale, design and data collection procedures of the Swedish CArdioPulmonary bioImage Study (SCAPIS) re-examination, which, in its further scope, aims to quantify and explain the development of atherosclerosis, pathological cardiovascular ageing, longitudinal decline in lung function and the malignant transformation of pulmonary nodules among middle-aged Swedes in the longitudinal SCAPIS.
Methods: SCAPIS re-examination is a prospective observational study reassessing approximately 15,000 participants (50% of the original SCAPIS cohort) from six university hospitals. Participants were aged 55–75 years at follow-up, occurring a median of 8.1 years after the baseline investigation. Standardized protocols replicated baseline imaging and functional assessments, including questionnaires, clinical assessments and extensive computer tomography imaging.
Results: Interim analyses of the first 5000 participants (50% women; median age 65.5 [61.8–69.1] years) indicated an expected age-related increase in the prevalence and treatment of hypertension (from 22% to 37%) and diabetes (from 4% to 8%), together with a modest rise in central adiposity. Body mass index (median 26.6 kg/m2) and the proportion of obesity (22%) remained largely stable, whereas current smoking decreased from 7.5% to 3.4%. The observed patterns were consistent in men and women.
Conclusion: Here we present the rationale, design, methods and management of incidental findings in the SCAPIS re-examination. By integrating serial imaging, functional testing and biomarker profiling, the re-examination will furnish unprecedented insight into cardiopulmonary disease dynamics in an ageing population. These data will underpin personalized risk prediction and inform preventive strategies, while serving as a benchmark for future population-based imaging cohorts.
Ort, förlag, år, upplaga, sidor
John Wiley & Sons, 2026. Vol. 299, nr 4, s. 467-480
Nyckelord [en]
atherosclerosis, longitudinal studies, preventive medicine
Nationell ämneskategori
Kardiologi och kardiovaskulära sjukdomar
Identifikatorer
URN: urn:nbn:se:umu:diva-249484DOI: 10.1111/joim.70068ISI: 001665371800001PubMedID: 41558989Scopus ID: 2-s2.0-105028124477OAI: oai:DiVA.org:umu-249484DiVA, id: diva2:2035431
2026-02-042026-02-042026-05-21Bibliografiskt granskad